Type 2 Diabetes: Perspective

• Popular Joint Supplement Cuts Nephropathy Risk in T2D People with type 2 diabetes who regularly use the supplement glucosamine have a lower risk for microvascular complications and diabetic nephropathy, a prospective observational study finds.
  Medscape Medical News, April 11, 2025
• ACC 2025 Little Learned From Trials That Are Positive by Design Dapagliflozin after TAVI? Semaglutide for claudication? Two trials designed to be positive should not warrant new indications for these drugs writes John Mandrola, MD.
  theheart.org on Medscape, April 10, 2025
• Keto Diet With SGLT2 Inhibitors May Contribute to DKA
  Medscape Diabetes & Endocrinology, April 10, 2025
• Inflammatory Marker Predicts Liver Cancer Risk in T2D An inflammatory biomarker, YKL-40, serves as a reliable prognostic marker for liver and bladder cancers in patients with newly diagnosed T2D, outperforming CRP for these cancers.
  Medscape News UK, April 10, 2025
• ACC 2025 Fluid Restriction in HF: Let’s Not Torture Patients   Drs Piña and Hsich discuss the FRESH-UP trial that challenged the dogma of fluid restriction in heart failure and provide practical strategies for optimizing medical therapy instead.
  theheart.org on Medscape, April 09, 2025
• GLP-1 Drugs Might Cut Dementia Risk in Half   New evidence brings more good news about the unanticipated effects of the GLP-1 receptor agonists.
  Medscape, April 07, 2025
• Diabetes Distress Linked to Autonomic Symptoms in Adults Diabetes distress positively correlates with increased symptoms of autonomic nervous system dysregulation in patients with type 1 or type 2 diabetes, a new study finds.
  Medscape Medical News, April 07, 2025
• Apr 04 2025 This Week in Cardiology   Trials from the 2025 American College of Cardiology scientific sessions, including the WARRIOR, PROTECT TAVI, DAPATAVI, and SOUL are reviewed by John Mandrola, MD
  theheart.org on Medscape, April 04, 2025
• Alternatives to GLP-1 Medications for Weight Loss   Dr Sarah Barenbaum discusses alternatives to GLP-1 medications for weight loss.
  Medscape, April 04, 2025
• Low sNRP-1 Levels Tied to Depression in Newly Diagnosed T2D Low levels of soluble neuropilin-1 are associated with depression in patients with newly diagnosed type 2 diabetes, highlighting their potential as a biomarker for mental health in this population.
  Medscape Medical News, April 04, 2025
• Smartwatch Motivates Patients With Diabetes to Stay Active A recent study shows that wearable technology can support patients with type 2 diabetes in maintaining purposeful exercise routines, which can in turn aid in managing their condition.
  Medscape News UK, April 03, 2025
• No Rise in T2D Risk After Mild COVID-19 in Vaccinated Adults No increased risk for new-onset T2D was found after mild SARS-CoV-2 infection in a multiethnic Asian cohort during the Omicron or Delta wave, particularly among fully vaccinated individuals.
  Medscape Medical News, April 03, 2025
• Driving With Diabetes? Let Your CGM Take the Wheel! Continuous glucose monitoring with low-glucose alerts shows potential for reducing hypoglycemia risk in insulin-treated drivers, thereby enhancing safety.
  Medscape Medical News, April 02, 2025
• Can Echocardiography Improve Outcomes in Type 2 Diabetes? Echocardiography is independently associated with survival time and readmission rates in patients with type 2 diabetes.
  Medscape Medical News, March 31, 2025
• Semaglutide Use Linked to Risk for Vision Loss in Diabetes Patients with diabetes who take semaglutide are at increased risk for NAION compared with patients who do not use GLP-1 RAs to control their blood sugar, a new study finds.
  Medscape Medical News, March 28, 2025
• When Should You Consider Weight-Loss Meds for Obesity?   Dr Sarah Barenbaum discusses when to consider antiobesity medications.
  Medscape, March 27, 2025
• How T2D Patients With Albuminuria Respond to Dapagliflozin? In patients with type 2 diabetes and albuminuria, dapagliflozin leads to a significant reduction in urine albumin-to-creatinine ratio, but with considerable variability in response among individuals.
  Medscape News UK, March 27, 2025
• Swedish Study Finds Link Between Asthma and Diabetes A study involving more than 5.2 million adults in Sweden finds a link between asthma and type 2 diabetes that persists even after accounting for BMI.
  Medscape News UK, March 27, 2025
• Which Diabetes Type Has Higher Stroke Risk? Type 1 diabetes increases the risk for both ischaemic and haemorrhagic stroke, whereas type 2 diabetes increases the risk for only ischaemic stroke, a study shows.
  Medscape News UK, March 26, 2025
• S3 Episode 3: The 2025 updates of the American Diabetes Association   Drs Carol H. Wysham and Rozalina G. McCoy discuss the 2025 updates of the American Diabetes Association, including comorbidities, dental care, sexual dysfunction, and CGM use.
  Medscape, March 25, 2025